EBV Early Antigens Antibody |
|
V2334-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (EaD) and restricted (EaR) components. The activity of EaD is suppressed during latent infection. BMRF1, the gene that encodes for EaD, is closely associated with the gene encoding for EBV DNA polymerase, and EaD is essential for the activity of this polymerase. EaD forms a complex with EBV DNase and, together, they may play a role in viral replication. |
Igg Antibody Laboratories manufactures the ebv antibody early antigenigg reagents distributed by Genprice. The Ebv Antibody Early Antigenigg reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Ebv products are available in stock. Specificity: Ebv Category: Antibody Group: Early Antigenigg
EBV Early Antigens Antibody |
|
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (EaD) and restricted (EaR) components. The activity of EaD is suppressed during latent infection. BMRF1, the gene that encodes for EaD, is closely associated with the gene encoding for EBV DNA polymerase, and EaD is essential for the activity of this polymerase. EaD forms a complex with EBV DNase and, together, they may play a role in viral replication. |
EBV Early Antigens Antibody |
|
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (EaD) and restricted (EaR) components. The activity of EaD is suppressed during latent infection. BMRF1, the gene that encodes for EaD, is closely associated with the gene encoding for EBV DNA polymerase, and EaD is essential for the activity of this polymerase. EaD forms a complex with EBV DNase and, together, they may play a role in viral replication. |
EBV Early Antigens Antibody |
|
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (EaD) and restricted (EaR) components. The activity of EaD is suppressed during latent infection. BMRF1, the gene that encodes for EaD, is closely associated with the gene encoding for EBV DNA polymerase, and EaD is essential for the activity of this polymerase. EaD forms a complex with EBV DNase and, together, they may play a role in viral replication. |
Early Antigenigg information
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNCB0103-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), Biotin conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNCB0103-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), Biotin conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNCP0103-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), PerCP conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNCA0103-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), APC conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNCAP0103-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNCAP0103-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC940103-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF594 conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC940103-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF594 conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNCH0103-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNCH0103-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC040103-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF405S conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC040103-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF405S conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC050103-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF405M conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC050103-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF405M conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC700103-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF770 conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC700103-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF770 conjugate, Concentration: 0.1mg/mL |
p55;50 EBV-Early Antigen(1108-1) Antibody |
|
BNC800103-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against p55;50 EBV-Early Antigen(1108-1), CF680 conjugate, Concentration: 0.1mg/mL |
